TGF β Antibodies

Santa Cruz Biotechnology features a diverse variety of TGF β monoclonal antibodies for investigating transforming growth factor beta (TGF β) in various biological processes. TGF β Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TGF β is a multifunctional cytokine that plays a critical role in cell growth, differentiation, and immune regulation. TGF β influences processes such as tissue repair, fibrosis, and the regulation of the immune response, making it a key player in both normal physiology and disease states, including cancer and autoimmune disorders. Understanding the signaling pathways and mechanisms of TGF β is essential for developing targeted therapies and advancing knowledge of various pathologies. Researchers worldwide rely on TGF β monoclonal antibodies to explore cellular mechanisms and pathways. TGF β monoclonal antibodies enable precise detection and analysis of protein expression, localization, and interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of TGF β's role in health and disease.